ALT Q1 2019 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+59754.0% YoY

Gross Profit

-$262,079-8.9% margin

Operating Income

-$2M-78.8% margin

Net Income

-$2M-71.0% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+14.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$407,714

Balance Sheet

Total Assets

$65M

Total Liabilities

$6M

Stockholders' Equity

$59M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4,938	+59754.0%
Gross Profit	-$262,079	-$6M	+95.4%
Operating Income	-$2M	-$6M	+61.2%
Net Income	-$2M	-$3M	+33.9%